aluates Reports

$ 0.0

Automative

Global Primary Ovarian Insufficiency (POI) Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-38P10466

Global Primary Ovarian Insufficiency POI Market Research Report 2022

BUY CHAPTERS

Global Primary Ovarian Insufficiency (POI) Market Research Report 2025

Code: QYRE-Auto-38P10466

Report

February 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Bayer

Novartis

Bioscience Institute

Johns Hopkins Medicine

Mayo Clinic

Baptist Health

Indira IVF

Primary Ovarian Insufficiency (POI) Market Size

The global market for Primary Ovarian Insufficiency (POI) was valued at US$ 768 million in the year 2024 and is projected to reach a revised size of US$ 1217 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Primary Ovarian Insufficiency (POI) Market

Primary ovarian insufficiency used to be called premature ovarian failure. It’s a condition that affects women well before they should reach menopause.

North American market for Primary Ovarian Insufficiency (POI) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Primary Ovarian Insufficiency (POI) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Primary Ovarian Insufficiency (POI) in Less than 20 Years Old is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Primary Ovarian Insufficiency (POI) include Pfizer, Bayer, Novartis, Bioscience Institute, Johns Hopkins Medicine, Mayo Clinic, Baptist Health, Indira IVF, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Primary Ovarian Insufficiency (POI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Primary Ovarian Insufficiency (POI).

The Primary Ovarian Insufficiency (POI) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Primary Ovarian Insufficiency (POI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Primary Ovarian Insufficiency (POI) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Primary Ovarian Insufficiency (POI) Market Report

Report Metric	Details
Report Name	Primary Ovarian Insufficiency (POI) Market
Accounted market size in year	US$ 768 million
Forecasted market size in 2031	US$ 1217 million
CAGR	6.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Hormone Replacement Therapy (HRT) Calcium and Vitamin D Supplements In Vitro Fertilization (IVF) Stem Cell Therapy Others
Segment by Application	Less than 20 Years Old 20 to 30 Years Old 30 to 45 Years Old 45 Years Old and Older
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Bayer, Novartis, Bioscience Institute, Johns Hopkins Medicine, Mayo Clinic, Baptist Health, Indira IVF
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Primary Ovarian Insufficiency (POI) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Primary Ovarian Insufficiency (POI) Market growing?

Ans: The Primary Ovarian Insufficiency (POI) Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Primary Ovarian Insufficiency (POI) Market size in 2031?

Ans: The Primary Ovarian Insufficiency (POI) Market size in 2031 will be US$ 1217 million.

Who are the main players in the Primary Ovarian Insufficiency (POI) Market report?

Ans: The main players in the Primary Ovarian Insufficiency (POI) Market are Pfizer, Bayer, Novartis, Bioscience Institute, Johns Hopkins Medicine, Mayo Clinic, Baptist Health, Indira IVF

What are the Application segmentation covered in the Primary Ovarian Insufficiency (POI) Market report?

Ans: The Applications covered in the Primary Ovarian Insufficiency (POI) Market report are Less than 20 Years Old, 20 to 30 Years Old, 30 to 45 Years Old, 45 Years Old and Older

What are the Type segmentation covered in the Primary Ovarian Insufficiency (POI) Market report?

Ans: The Types covered in the Primary Ovarian Insufficiency (POI) Market report are Hormone Replacement Therapy (HRT), Calcium and Vitamin D Supplements, In Vitro Fertilization (IVF), Stem Cell Therapy, Others

Recommended Reports

Fertility and Reproductive

Gynecology and Menopause

Women's Health Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Primary Ovarian Insufficiency (POI) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Hormone Replacement Therapy (HRT)

1.2.3 Calcium and Vitamin D Supplements

1.2.4 In Vitro Fertilization (IVF)

1.2.5 Stem Cell Therapy

1.2.6 Others

1.3 Market by Application

1.3.1 Global Primary Ovarian Insufficiency (POI) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Less than 20 Years Old

1.3.3 20 to 30 Years Old

1.3.4 30 to 45 Years Old

1.3.5 45 Years Old and Older

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Primary Ovarian Insufficiency (POI) Market Perspective (2020-2031)

2.2 Global Primary Ovarian Insufficiency (POI) Growth Trends by Region

2.2.1 Global Primary Ovarian Insufficiency (POI) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Primary Ovarian Insufficiency (POI) Historic Market Size by Region (2020-2025)

2.2.3 Primary Ovarian Insufficiency (POI) Forecasted Market Size by Region (2026-2031)

2.3 Primary Ovarian Insufficiency (POI) Market Dynamics

2.3.1 Primary Ovarian Insufficiency (POI) Industry Trends

2.3.2 Primary Ovarian Insufficiency (POI) Market Drivers

2.3.3 Primary Ovarian Insufficiency (POI) Market Challenges

2.3.4 Primary Ovarian Insufficiency (POI) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Primary Ovarian Insufficiency (POI) Players by Revenue

3.1.1 Global Top Primary Ovarian Insufficiency (POI) Players by Revenue (2020-2025)

3.1.2 Global Primary Ovarian Insufficiency (POI) Revenue Market Share by Players (2020-2025)

3.2 Global Primary Ovarian Insufficiency (POI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Primary Ovarian Insufficiency (POI) Revenue

3.4 Global Primary Ovarian Insufficiency (POI) Market Concentration Ratio

3.4.1 Global Primary Ovarian Insufficiency (POI) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Primary Ovarian Insufficiency (POI) Revenue in 2024

3.5 Global Key Players of Primary Ovarian Insufficiency (POI) Head office and Area Served

3.6 Global Key Players of Primary Ovarian Insufficiency (POI), Product and Application

3.7 Global Key Players of Primary Ovarian Insufficiency (POI), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Primary Ovarian Insufficiency (POI) Breakdown Data by Type

4.1 Global Primary Ovarian Insufficiency (POI) Historic Market Size by Type (2020-2025)

4.2 Global Primary Ovarian Insufficiency (POI) Forecasted Market Size by Type (2026-2031)

5 Primary Ovarian Insufficiency (POI) Breakdown Data by Application

5.1 Global Primary Ovarian Insufficiency (POI) Historic Market Size by Application (2020-2025)

5.2 Global Primary Ovarian Insufficiency (POI) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Primary Ovarian Insufficiency (POI) Market Size (2020-2031)

6.2 North America Primary Ovarian Insufficiency (POI) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Primary Ovarian Insufficiency (POI) Market Size by Country (2020-2025)

6.4 North America Primary Ovarian Insufficiency (POI) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Primary Ovarian Insufficiency (POI) Market Size (2020-2031)

7.2 Europe Primary Ovarian Insufficiency (POI) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Primary Ovarian Insufficiency (POI) Market Size by Country (2020-2025)

7.4 Europe Primary Ovarian Insufficiency (POI) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size (2020-2031)

8.2 Asia-Pacific Primary Ovarian Insufficiency (POI) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size by Region (2020-2025)

8.4 Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Primary Ovarian Insufficiency (POI) Market Size (2020-2031)

9.2 Latin America Primary Ovarian Insufficiency (POI) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Primary Ovarian Insufficiency (POI) Market Size by Country (2020-2025)

9.4 Latin America Primary Ovarian Insufficiency (POI) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size (2020-2031)

10.2 Middle East & Africa Primary Ovarian Insufficiency (POI) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size by Country (2020-2025)

10.4 Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Primary Ovarian Insufficiency (POI) Introduction

11.1.4 Pfizer Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Bayer Business Overview

11.2.3 Bayer Primary Ovarian Insufficiency (POI) Introduction

11.2.4 Bayer Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025)

11.2.5 Bayer Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Primary Ovarian Insufficiency (POI) Introduction

11.3.4 Novartis Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Bioscience Institute

11.4.1 Bioscience Institute Company Details

11.4.2 Bioscience Institute Business Overview

11.4.3 Bioscience Institute Primary Ovarian Insufficiency (POI) Introduction

11.4.4 Bioscience Institute Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025)

11.4.5 Bioscience Institute Recent Development

11.5 Johns Hopkins Medicine

11.5.1 Johns Hopkins Medicine Company Details

11.5.2 Johns Hopkins Medicine Business Overview

11.5.3 Johns Hopkins Medicine Primary Ovarian Insufficiency (POI) Introduction

11.5.4 Johns Hopkins Medicine Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025)

11.5.5 Johns Hopkins Medicine Recent Development

11.6 Mayo Clinic

11.6.1 Mayo Clinic Company Details

11.6.2 Mayo Clinic Business Overview

11.6.3 Mayo Clinic Primary Ovarian Insufficiency (POI) Introduction

11.6.4 Mayo Clinic Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025)

11.6.5 Mayo Clinic Recent Development

11.7 Baptist Health

11.7.1 Baptist Health Company Details

11.7.2 Baptist Health Business Overview

11.7.3 Baptist Health Primary Ovarian Insufficiency (POI) Introduction

11.7.4 Baptist Health Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025)

11.7.5 Baptist Health Recent Development

11.8 Indira IVF

11.8.1 Indira IVF Company Details

11.8.2 Indira IVF Business Overview

11.8.3 Indira IVF Primary Ovarian Insufficiency (POI) Introduction

11.8.4 Indira IVF Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025)

11.8.5 Indira IVF Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Bayer

Novartis

Bioscience Institute

Johns Hopkins Medicine

Mayo Clinic

Baptist Health

Indira IVF

List of Tables

Table 1. Global Primary Ovarian Insufficiency (POI) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Hormone Replacement Therapy (HRT)

Table 3. Key Players of Calcium and Vitamin D Supplements

Table 4. Key Players of In Vitro Fertilization (IVF)

Table 5. Key Players of Stem Cell Therapy

Table 6. Key Players of Others

Table 7. Global Primary Ovarian Insufficiency (POI) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Primary Ovarian Insufficiency (POI) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Primary Ovarian Insufficiency (POI) Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Primary Ovarian Insufficiency (POI) Market Share by Region (2020-2025)

Table 11. Global Primary Ovarian Insufficiency (POI) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Primary Ovarian Insufficiency (POI) Market Share by Region (2026-2031)

Table 13. Primary Ovarian Insufficiency (POI) Market Trends

Table 14. Primary Ovarian Insufficiency (POI) Market Drivers

Table 15. Primary Ovarian Insufficiency (POI) Market Challenges

Table 16. Primary Ovarian Insufficiency (POI) Market Restraints

Table 17. Global Primary Ovarian Insufficiency (POI) Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Primary Ovarian Insufficiency (POI) Market Share by Players (2020-2025)

Table 19. Global Top Primary Ovarian Insufficiency (POI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Ovarian Insufficiency (POI) as of 2024)

Table 20. Ranking of Global Top Primary Ovarian Insufficiency (POI) Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Primary Ovarian Insufficiency (POI) Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Primary Ovarian Insufficiency (POI), Headquarters and Area Served

Table 23. Global Key Players of Primary Ovarian Insufficiency (POI), Product and Application

Table 24. Global Key Players of Primary Ovarian Insufficiency (POI), Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Primary Ovarian Insufficiency (POI) Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Primary Ovarian Insufficiency (POI) Revenue Market Share by Type (2020-2025)

Table 28. Global Primary Ovarian Insufficiency (POI) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Primary Ovarian Insufficiency (POI) Revenue Market Share by Type (2026-2031)

Table 30. Global Primary Ovarian Insufficiency (POI) Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Primary Ovarian Insufficiency (POI) Revenue Market Share by Application (2020-2025)

Table 32. Global Primary Ovarian Insufficiency (POI) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Primary Ovarian Insufficiency (POI) Revenue Market Share by Application (2026-2031)

Table 34. North America Primary Ovarian Insufficiency (POI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Primary Ovarian Insufficiency (POI) Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Primary Ovarian Insufficiency (POI) Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Primary Ovarian Insufficiency (POI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Primary Ovarian Insufficiency (POI) Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Primary Ovarian Insufficiency (POI) Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Primary Ovarian Insufficiency (POI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Primary Ovarian Insufficiency (POI) Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Primary Ovarian Insufficiency (POI) Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size by Country (2026-2031) & (US$ Million)

Table 49. Pfizer Company Details

Table 50. Pfizer Business Overview

Table 51. Pfizer Primary Ovarian Insufficiency (POI) Product

Table 52. Pfizer Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025) & (US$ Million)

Table 53. Pfizer Recent Development

Table 54. Bayer Company Details

Table 55. Bayer Business Overview

Table 56. Bayer Primary Ovarian Insufficiency (POI) Product

Table 57. Bayer Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025) & (US$ Million)

Table 58. Bayer Recent Development

Table 59. Novartis Company Details

Table 60. Novartis Business Overview

Table 61. Novartis Primary Ovarian Insufficiency (POI) Product

Table 62. Novartis Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025) & (US$ Million)

Table 63. Novartis Recent Development

Table 64. Bioscience Institute Company Details

Table 65. Bioscience Institute Business Overview

Table 66. Bioscience Institute Primary Ovarian Insufficiency (POI) Product

Table 67. Bioscience Institute Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025) & (US$ Million)

Table 68. Bioscience Institute Recent Development

Table 69. Johns Hopkins Medicine Company Details

Table 70. Johns Hopkins Medicine Business Overview

Table 71. Johns Hopkins Medicine Primary Ovarian Insufficiency (POI) Product

Table 72. Johns Hopkins Medicine Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025) & (US$ Million)

Table 73. Johns Hopkins Medicine Recent Development

Table 74. Mayo Clinic Company Details

Table 75. Mayo Clinic Business Overview

Table 76. Mayo Clinic Primary Ovarian Insufficiency (POI) Product

Table 77. Mayo Clinic Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025) & (US$ Million)

Table 78. Mayo Clinic Recent Development

Table 79. Baptist Health Company Details

Table 80. Baptist Health Business Overview

Table 81. Baptist Health Primary Ovarian Insufficiency (POI) Product

Table 82. Baptist Health Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025) & (US$ Million)

Table 83. Baptist Health Recent Development

Table 84. Indira IVF Company Details

Table 85. Indira IVF Business Overview

Table 86. Indira IVF Primary Ovarian Insufficiency (POI) Product

Table 87. Indira IVF Revenue in Primary Ovarian Insufficiency (POI) Business (2020-2025) & (US$ Million)

Table 88. Indira IVF Recent Development

Table 89. Research Programs/Design for This Report

Table 90. Key Data Information from Secondary Sources

Table 91. Key Data Information from Primary Sources

Table 92. Authors List of This Report

List of Figures

Figure 1. Primary Ovarian Insufficiency (POI) Picture

Figure 2. Global Primary Ovarian Insufficiency (POI) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Primary Ovarian Insufficiency (POI) Market Share by Type: 2024 VS 2031

Figure 4. Hormone Replacement Therapy (HRT) Features

Figure 5. Calcium and Vitamin D Supplements Features

Figure 6. In Vitro Fertilization (IVF) Features

Figure 7. Stem Cell Therapy Features

Figure 8. Others Features

Figure 9. Global Primary Ovarian Insufficiency (POI) Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Primary Ovarian Insufficiency (POI) Market Share by Application: 2024 VS 2031

Figure 11. Less than 20 Years Old Case Studies

Figure 12. 20 to 30 Years Old Case Studies

Figure 13. 30 to 45 Years Old Case Studies

Figure 14. 45 Years Old and Older Case Studies

Figure 15. Primary Ovarian Insufficiency (POI) Report Years Considered

Figure 16. Global Primary Ovarian Insufficiency (POI) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Primary Ovarian Insufficiency (POI) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Primary Ovarian Insufficiency (POI) Market Share by Region: 2024 VS 2031

Figure 19. Global Primary Ovarian Insufficiency (POI) Market Share by Players in 2024

Figure 20. Global Top Primary Ovarian Insufficiency (POI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Ovarian Insufficiency (POI) as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Primary Ovarian Insufficiency (POI) Revenue in 2024

Figure 22. North America Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Primary Ovarian Insufficiency (POI) Market Share by Country (2020-2031)

Figure 24. United States Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Primary Ovarian Insufficiency (POI) Market Share by Country (2020-2031)

Figure 28. Germany Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Primary Ovarian Insufficiency (POI) Market Share by Region (2020-2031)

Figure 36. China Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Primary Ovarian Insufficiency (POI) Market Share by Country (2020-2031)

Figure 44. Mexico Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Primary Ovarian Insufficiency (POI) Market Share by Country (2020-2031)

Figure 48. Turkey Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Primary Ovarian Insufficiency (POI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Pfizer Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2020-2025)

Figure 52. Bayer Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2020-2025)

Figure 54. Bioscience Institute Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2020-2025)

Figure 55. Johns Hopkins Medicine Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2020-2025)

Figure 56. Mayo Clinic Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2020-2025)

Figure 57. Baptist Health Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2020-2025)

Figure 58. Indira IVF Revenue Growth Rate in Primary Ovarian Insufficiency (POI) Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Premature Ovarian Insufficiency POI Treatment Market Research Report 2025

Global Premature Ovarian Insufficiency Treatment Market Research Report 2025

Global Premature Ovarian Failure POF Treatment Market Research Report 2025

Global Premature Ovarian Failure Treatment Market Research Report 2025

Global Premature Ovarian Failure Cure Market Research Report 2025

Global Primary Ovarian Insufficiency POI Treatment Market Research Report 2025

Global Primary Ovarian Insufficiency Therapy Market Research Report 2025

Global Primary Ovarian Insufficiency Treatment Market Research Report 2025

Global Polycystic Ovary Syndrome Treatment Market Insights Forecast to 2030

Global Infertility Therapies Market Insights Forecast to 2030

Global Polycystic Ovary Syndrome PCOS Treatment Market Research Report 2024

Polycystic Ovarian Syndrome PCOS Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Male Infertility Market Research Report 2024

Global Women s Home based Health Testing Services Market Research Report 2025

Ovarian Reserve Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Addison s Disease Treatment Market Insights Forecast to 2030

Global Polycystic Ovarian Syndrome PCOS Therapeutics Market Insights Forecast to 2030

Postmenopausal Vaginal Atrophy Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

IVF Devices and Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions